Peptides for Endurance Athletes: What Triathletes and Ironman Competitors Should Know

Six Weeks Out From Kona

Every long-course triathlete knows some version of this moment. The fitness is there. The body that has to express it is the thing breaking down. A 70.3 brick, an Ironman build, a marathon block off the back of a heavy bike week. The aerobic engine adapts faster than the tendons and the cellular recovery machinery can keep up, and the gap between the two is where seasons get lost.

Peptide therapy has become part of how some endurance athletes try to close that gap. Most of the content about it online is either gray-market suppliers selling vials or generic listicles that miss what actually wears out in endurance sport. This guide is organized around the three systems that long-course racing actually taxes, the peptide that maps to each, and an honest section on the anti-doping rules, because if you race tested events, that part is not optional reading.

Three Systems, Three Tools

Strength sport breaks down in one way, mostly: connective tissue under maximal load. Endurance is different. It breaks down in three ways at once, and they are on different clocks.

The mistake most people make is treating peptides as one interchangeable category. They are not. Matching the molecule to the system it actually acts on is the entire point, and it is what the rest of this guide walks through.

The Engine: MOTS-c

MOTS-c is the peptide most directly tied to endurance. It was discovered at the University of Southern California in 2015, and it is notable for a strange reason: it is the first peptide ever found to be encoded by mitochondrial DNA rather than the DNA in the cell nucleus. The mitochondria, in other words, make their own signaling peptide, and MOTS-c is it.

In animal studies MOTS-c behaves like an exercise mimetic. It activates the AMPK pathway, improves insulin sensitivity, increases fat oxidation, and supports the metabolic flexibility that lets a body burn fat efficiently deep into a long effort. For an endurance athlete, that last part is the interesting one. The difference between bonking at hour seven and holding pace is largely a story about fuel utilization at the mitochondrial level.

Because of that timeline, athletes who use it tend to start it during a base or build block, well before the goal race, rather than reaching for it race week. Endurance athletes training at altitude in places like Boulder or Flagstaff sometimes start it earlier in the build, since altitude amplifies the mitochondrial demand. There is more on that pattern in the MOTS-c at altitude guide.

The Injuries: BPC-157 and the Tendons That End Seasons

Ask a physical therapist what takes triathletes off the road and the answer is rarely a dramatic tear. It is the slow tendinopathies that build over a heavy block and then refuse to settle. The big four are the Achilles tendon, the plantar fascia, the iliotibial band, and the patellar tendon. These are connective-tissue structures with poor blood supply, which is exactly why they heal slowly and why ice, rest, and a foam roller often are not enough on their own.

BPC-157 is the peptide most associated with this category. The research base is largely preclinical, but it is consistent: BPC-157 appears to support angiogenesis (the growth of new blood vessels into healing tissue) and to accelerate the repair of tendon, ligament, and other soft tissue in animal models. For tissue that is starved of blood flow to begin with, the angiogenesis mechanism is the part that makes mechanistic sense for tendons specifically.

For more stubborn or higher-grade soft-tissue work, some athletes use the BPC-157/TB-500 combo. TB-500 (a synthetic fragment related to thymosin beta-4) works through a complementary mechanism involving cell migration and actin regulation, and the combination is the more aggressive soft-tissue protocol. The single peptide is the more common starting point.

For skin and connective-tissue support more broadly, GHK-Cu sometimes enters the picture, though it is a secondary tool for this persona rather than a core one. The recovery-focused peptides are collected on the best peptides for recovery and tendon pages.

Between Sessions: NAD+

The third system is the one nobody sees: what happens in the 18 hours between a hard brick and the next session. Recovery is not passive. It is an energy-expensive cellular process, and a lot of it runs on NAD+, a coenzyme central to how cells produce and manage energy. Heavy training drains the NAD+ pool faster than easy weeks do, and a depleted pool is part of why peak-build fatigue feels different from ordinary tiredness.

NAD+ therapy is used to support that energy side of recovery during the highest-load phases of a training plan. Athletes commonly run it at a maintenance dose through a build block and bump it after the biggest weekly session, when the cellular repair load is highest. It pairs naturally with the sleep and nutrition fundamentals that actually do most of the recovery work. No peptide outranks eight hours of sleep and adequate carbohydrate.

A Note on CJC-1295/Ipamorelin

CJC-1295/Ipamorelin comes up in endurance circles, usually for masters athletes (40+). It supports the natural overnight growth-hormone pulse, which is when a meaningful share of tissue recovery happens. For an older athlete fighting the slow erosion of recovery capacity and lean mass, that can be useful in an off-season or base block.

The WADA Question (Read This)

This is the section most peptide content skips, and for triathletes it is the most important one. If you compete in tested events, the anti-doping rules are not a footnote.

Who does this actually apply to? Elite and professional triathletes, and age-group athletes competing in ITU/World Triathlon and many Ironman championship qualifying events, can be tested. If that is you, treat the substances in this guide as off-limits for competition and verify everything against the current WADA Prohibited List, which updates every January. The responsibility for racing clean within your category rests with you, and "I did not know" is not a defense under strict liability.

Who does it not apply to? The large majority of recreational and age-group athletes who train for personal goals and local races that do not test. For them, the testing risk is simply not part of the picture. What does still apply to everyone: these are prescription-only substances in the US, they are not FDA-approved for performance or recovery, and getting them legally means an evaluation by a licensed provider rather than a vial from an unregulated website. We cite WADA and USADA here rather than trying to argue around them, because the credible position is the honest one.

Timing Around Bricks and Race Week

For untested athletes who have cleared the prescription side with a provider, the practical questions are about when, not whether. A few patterns that come up repeatedly:

During the build. MOTS-c runs through the base and build blocks where the mitochondrial adaptation is happening. NAD+ sits at maintenance and bumps after the biggest weekly session. BPC-157 is either addressing a specific nagging tendon or held in reserve. This is the phase where the load is highest and the support matters most.

Race week. Taper applies to peptides too. Do not introduce anything new in the final week, and do not dose anything novel on race morning. Whatever your settled routine is, that is the routine. The goal of race week is to arrive rested and light, not to chase a last-minute edge.

Post-race. A full-distance race produces real tissue and cellular damage, and the 7 to 14 days after are where recovery peptides do high-leverage work. NAD+ at an elevated dose for the first week, BPC-157 daily for anything that got beat up, then easy aerobic work before any intensity returns. The endurance-overlap personas, like gravel cyclists, use a very similar recovery window.

A Few Practical Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed June 2026